| VIDAC PHARMA HLDG PLC LS1 |
| Großbritannien |
| Gesundheit |
| GB00BM9XQ619 / A3DTUQ |
| T9G (Frankfurt) |
| FRA:T9G, ETR:T9G, T9G:GR |
| - |
| https://vidacpharma.com/ |
|
Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases. The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical ..
>Volltext.. |
| 30.75 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| VIDAC PHARMA |
| 04.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|